Back to search

Article

What Do We Know About and What Could Be the Strategy Adopted to Treat Mucormycosis on Post-COVID-19 Cases? Is It an Adjuvant Nanomaterial?

2021-08-22

Abstract excerpt

Unfortunately, Coronavirus disease 2019 (COVID-19) remains a significant public health issue worldwide, mainly in the USA, India and Brazil. The 2nd wave of COVID-19 has reached India first. The country has been making great effort to stabilize its current condition but, unfortunately, mucormycosis infection (or black fungus) associated with COVID-19 has emerged as another threat to the country and, most likely, t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7dbcf43e-d1ad-5372-8eac-e711cf9fb319
DOI
10.21467/preprints.330
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
What Do We Know About and What Could Be the Strategy Adopted to Treat Mucormycosis on Post-COVID-19 Cases? Is It an Adjuvant Nanomaterial?DOI 10.21467/preprints.330
Select a neighboring publication to make it the new centre.